Elsevier Announces Finalists of the 2020 Reaxys® PhD Prize

Elsevier Announces Finalists of the 2020 Reaxys® PhD Prize

PR Newswire

AMSTERDAM, July 8, 2020

Marking its 10th anniversary, this year's Reaxys PhD Prize finalists will be recognized for their innovative and original research in chemistry and associated sciences

AMSTERDAM, July 8, 2020 /PRNewswire/ -- Elsevier, a global leader in research publishing and information analytics, is pleased to announce the 45 finalists for the 2020 Reaxys PhD Prize.

This year's Reaxys PhD Prize Finalists represent 12 countries and 30 universities from around the world

Launched in 2010, the Reaxys PhD Prize celebrates innovative and rigorous research by ambitious early career chemical sciences researchers. This year's competition maintained the high standards of previous years: over 400 entries from around the globe were rigorously examined by the Review Committee to arrive at the 45 finalists.

"This year continues the tradition of excellence of the Reaxys Prize in attracting hundreds of outstanding applications from all across the globe," said Reaxys Advisory Board member Professor Donna Huryn, a Principal Investigator at the University of Pittsburgh Chemical Diversity Center. "Equally impressive are the 45 finalists, and that they represent the breadth of our field in terms of geography as well as discipline.  I am looking forward to what will be an exceptional symposium.''

The 45 finalists are invited to attend the virtual Reaxys PhD Prize Symposium that will be held from September 30 to October 2, 2020. While normally an in-person event, this year's celebratory gathering will be online to ensure that all finalists can attend—regardless of any travel restrictions that may be in place in their home countries. A pre-registration link is available on the symposium page for anyone interested in joining the online event. The event will feature talks, including a keynote presentation from renowned University of California chemist Professor Bruce Lipshutz and a virtual poster session. The organizers also have special plans to support networking.

Fellow Advisory Board member, Professor Zhaomin Hou, Chief Scientist and Director of the Organometallic Chemistry Laboratory at the RIKEN Research Institute in Japan added that he was profoundly impressed by the number of high-quality submissions in 2020. "The PhD Prize brings together young and enthusiastic scientists to showcase their newest discoveries and to test new scientific ideas in open discussions."

During the virtual symposium, the ten short-listed finalists will give oral presentations of their research. From these presentations, the Reaxys Advisory Board will select the three winners of the Reaxys PhD Prize 2020. The winners will be announced on the final day of the symposium.

"Innovative young researchers from all over the world entered and we plan to celebrate their achievements as we do each year," said Dr. Friedrich Kroll, Elsevier's Senior Manager of Scientific Affairs and co-organizer of the competition. "We are delighted to see the competition continue to draw this number and quality of submissions.

"The opportunity to establish networks to address current scientific challenges, particularly ones requiring interdisciplinary solutions, is an important aspect of the event. We're also inviting our largest ever audience, with attendees from all previous years."

All finalists will receive lifelong membership in the Reaxys Prize Club, an exclusive international network of chemists from all research areas and career paths. Members also receive unlimited access to Elsevier's research solutions Reaxys and Reaxys Medicinal Chemistry.

This year's finalists and their PhD institutions are:

Find out more about the Reaxys PhD Prize.

About Elsevier

Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we're committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com

Photo - https://mma.prnewswire.com/media/1201695/Elsevier_finalists_2020.jpg
Logo - https://mma.prnewswire.com/media/754760/Elsevier_Logo.jpg

Media contact

Jonathan Davis
Elsevier Communications, Europe
+31 20 485 2719


Elsevier Logo


Voltar noticias em Inglês